Abstract-Halloysite is a nanostructured clay mineral with hollow tubular structure, which has recently found an important role as delivery system for drugs or other active molecules. One of these is curcumin, main constituent in the rhizome of the plant Curcuma Longa, with a series of useful pharmacological activities, hindered by its poor bioavalaibility and solubility in water. In this study, Halloysite clay nanotubes (HNTs) were characterized in terms of both structure and biocompatibility and they were used for curcumin delivery to cancer cells. The performed 3-(4, 5-dimethythiazol-2-yl)-2, 5-diphenyl-tetrazolium bromide (MTT) assay showed that HNTs have a high biocompatibility, also when coated with polymers, while curcumin is highly toxic for cancer cells. C. Dionisi is with the University of Pisa, Pisa 56126, Italy, and also with the CNR NANOTEC Istituto di Nanotecnologia, Lecce 73100, Italy (e-mail: chiaradionisi@live.it).
I. INTRODUCTION

I
N recent years, the increasing interest in nanoscience has led to the development of new carriers with advanced properties, such as liposomes, nanocapsules and carbon nanotubes, and also to the investigation of naturally occurred nanostructured materials. Halloysite (Al 2 Si 2 O 5 (OH) 4 ·nH 2 O) is a natural aluminosilicate clay, similar to kaolin, which presents a predominant tubular structure in the submicrometer range [1] . Halloysite nanotubes (HNTs) have an average length of 1 μm, with an external diameter of around 50 nm and an inner diameter of about 15 nm. As shown by scanning electron microscopy (SEM) and transmission electron microscopy (TEM) images HNTs are nano-tubular, rolled and hollow (see Fig. 1 ). The use of HNTs presents some advantages over other systems: they are naturally occurred, easily available, not expensive, and the loading procedure is quite simple [2] , [3] .
Thus, HNTs have recently found an important role as carriers for the delivery and controlled release of drugs or biologically active molecules [4] . HNTs have also shown to be highly biocompatible as demonstrated in in vitro [5] , [6] and in vivo studies [7] . Curcumin is a naturally occurred polyphenol, main constituent in the rhizome of the plant Curcuma Longa, grown in tropical Southeast Asia. It exhibits anti-inflammatory, anticancer and antioxidant activities, and has been shown to be safe even at high doses [8] .
However, the pharmaceutical potential of curcumin is hindered by its low solubility in water and bioavailability after oral administration, hence the use of a carrier vehicle to transport it to the desired targets is strongly needed.
In this paper, the structure of HNTs has been analyzed by SEM and TEM. HNTs have been used for the delivery and controlled release of curcumin. In order to provide an additional control over the drug release rate, HNTs have been coated with two different polyelectrolyte, Poly-L-lysine (PLL) and PolyAcrilic-Acid (PAA), by using the layer-by-layer (LbL) technique. The loading efficiency and the in vitro release kinetics have been spectrophotometrically analyzed, while the cell viability (CV) assay 3-(4, 5-dimethythiazol-2-yl)-2, 5-diphenyltetrazolium bromide MTT has been used to determine the apoptotic effect of curcumin and the biocompatibility of naked and coated HNTs. The effect on CV of loaded HNTs has been analyzed by means of the Trypan Blue Assay. Zeta potential has been used to follow successful polyelectrolyte multilayers coating of HNTs whereas the successful internalization of naked and curcumin-loaded Halloysite clay nanotubes inside breast cancer cells has been demonstrated by using Confocal laser scanning microscopy (CLSM).
II. MATERIALS AND METHODS
A. Reagents and Materials
Purified dehydrate HNTs were obtained from Applied Minerals, Inc. (New York, NY, USA) Curcumin and Trypan Blue Solution (0.4% in phosphate buffered saline (PBS)) were purchased from Sigma Aldrich (Milan, Italy). Dialysis membranes (Spectra/por, MWCO 12-14 KDa) were purchased from Fisher Scientific (Rancho Dominguez, CA, USA). Dulbecco's modified Eagle's Medium (DMEM), Fetal Bovine Serum (FBS), L-glutamine, Penicillin/Streptomycin, Trypsin thiazolyl blue tetrazolium bromide, Dimethyl sulfoxide (DMSO) and MTT were purchased from Sigma-Aldrich (Milan, Italy). PBS was purchased from Oxoid Limited (Basingstoke, Hampshire, U.K.). PLL and PAA were purchased from Sigma-Aldrich (Milan, Italy).
B. Loading Procedure
In order to entrap the drug inside the tubes, 3 mg of HNTs was mixed, as dry powder, with few microliters of a saturated solution of curcumin in absolute ethanol (5 mg/mL). The solution was then evacuated in a vacuum jar overnight. After the loading procedure, the Halloysite suspension was washed twice with ethanol 50% (distilled water/ethanol 50% v/v); the supernatant was collected, diluted and analyzed for curcumin content by spectrophotometer (UV-Vis Spectrophotometer Varian Cary 300 Scan) at a λ max value of 425 nm. A calibration curve (R 2 > 0.999) of curcumin in ethanol 50% was prepared prior to the assay using standard solutions ranging in concentration from 0.5 to 10 μg/mL.
The drug encapsulation efficiency (EE) and the loading efficiency (LE) were calculated using the following equations:
where C total , C sup were the total amount of curcumin added and the amount of drug in the supernatant, respectively, while C loaded was the weight of curcumin associated to HNTs, and H total was the total weight of used tubes.
C. Drug Release Analysis
The in vitro release of curcumin from loaded HNTs was studied by the dialysis bag method in phosphate-buffered saline (PBS pH 7.4) and ethanol (50% v/v). The dialysis bag was soaked in the release medium for 1 h before use. First, a few milligrams of loaded HNTs were dispersed in 1 mL of PBSethanol and the solution was introduced in a dialysis tube. It was then placed in a beaker containing 150 mL of the same release medium, maintained at 37°C in constant stirring. At regular time intervals, 1 mL of the external medium was withdrawn and replaced with the same volume of fresh solvent to maintain sink conditions. Care was taken to protect curcumin against light [9] .
Two different experiments were conducted in the same time, one for loaded HNTs and the other with the same amount of free curcumin in the dialysis bag, as control.
The concentration of drug in the release samples was determined spectrophotometrically at 425 nm, using 1 mL of pure medium as blank.
A calibration curve (R 2 > 0.999) of curcumin in the release medium had been previously prepared using standard solutions ranging from 0.5 to 10 μg/mL.
The cumulative percent of drug release (CPR) was plotted as a function of the dialysis time. It was calculated by the following equation:
where C rel was the amount of curcumin in the external release medium, that had been released from HNTs, and C load was the calculated weight of curcumin loaded into HNTs.
D. HNTs Coating
HNTs were coated by LbL technique, using two different polymers, PLL as positive electrolyte, and PAA as negative electrolyte. The PLL is a non toxic and stable material, soluble in water, and its solubility is not affected by pH basically. The PAA is anionic in water at neutral pH. Two solution of PLL and PAA were prepared in milliQ water at a concentration of 2 mg/mL.
For each layer, HNTs were incubated for 10 min with the corresponding polymers solution, in constant stirring. Then, the excess of polyelectrolyte was removed with three washing steps in NaCl 0.1 M. The procedure was repeated three times, resulting in the deposition of three layers on the tubes surface. The process efficiency was evaluated by measuring the surface ζ-potential, using a Nano ZS90 (Malvern Instrument, U.K.).
E. Cell Line and Culture Conditions
The MCF-7 breast cancer cell line was maintained in DMEM supplemented with 10% FBS, 5% L-glutamine, penicillin (100 U/mL) streptomycin (100 U/mL) and 5% sodium pyruvate. Cells were cultured at 37°C in CO 2 incubator in a humidified atmosphere, and maintained in continuous exponential growth by twice a week passage.
F. MTT Assay
The MTT colorimetric assay was performed to determine the antitumor effect of curcumin and the biocompatibility of HNTs, either naked or coated. This test is based on the selective ability of living cell to reduce the yellow soluble salt, MTT, to a purple-blue insoluble formazan precipitate.
In the first case, 10 000 cells/well were seeded in triplicate in a 96-well plate in presence of different solutions of curcumin in ethanol, ranging from 5 to 100 μg/mL, and were left in incubation for 24 to 48 to 72 h. At the end of the incubation period, the medium was removed and replaced with 100 μl/well of a solution of MTT in PBS (0.5 mg/mL). The plate was further incubated for 2 h, and then the converted dye was solubilized with 100 μL of DMSO. The quantity of formazan (presumably directly proportional to the number of viable cells) was measured by recording changes in absorbance at 570 nm using a plate reader spectrophotometer. The test with naked and coated HNTs was performed by seeding 20 000 cells/well in a 24-well plate. Cells were left to grow for 24 h, and then were treated with increasing concentrations of clay nanotubes, from 50 to 1000 μg/mL. Three different plates were prepared, for 24, 48 and 72 h of incubation, respectively. For 24-well plates, 200 μL/well of MTT and 200 μL/well of DMSO were used.
The CV was expressed as relative growth rate (RGR), by the formula:
where OD sample and OD control were the optical densities at 570 nm for each treatment and for a plate of control, left to grow in complete medium, respectively.
G. Trypan Blue Exclusion Assay
The Trypan Blue Exclusion Assay is based on the principle that viable cells with intact plasma membranes exclude Trypan Blue stain, whereas membrane permeable (non viable) cells stain dark blue. For this test, cells were seeded at a concentration of 200 000 cells/well into a 6-well plate, and left in incubation for 24 h. The day after, they were treated with an increasing amount of loaded HNTs, from 50 to 500 μg/mL, and left in further incubation for 24 to 72 h. At the end of each incubation period, the medium and the cells were collected. Cells were collected by trypsinization and resuspended in 1 mL of medium. The appropriate volume from the cell suspension was taken and diluted with the same amount of Trypan Blue (0, 4% in PBS). The excluding non-staining or staining cells were counted by a hemocytometer under a light microscope. For each treatment, the CV was expressed as:
where S cells and NS cells were the counted cells that had or not taken up the dye.
H. Confocal Laser Scanning Microscopy
CLSM images of Un-Loaded and Curcumin-Loaded HNTs uptake and release have been acquired by using a 63X objective of a TCSP5 Confocal Microscope (Leica Microsystem GmbH), Mannheim, Germany). Uptake is investigated after 24 h of incubation af HNTs at a concentration of 100 μg/mL. Transmission and Fluorescence optical sections are simultaneously acquired by using FITC and DAPI filters. MCF-7 nuclea are detected by DAPI whereas spontaneous release of curcumin after internalization from HNTs is detected by FITC filters. Un-loaded and polyelectrolyte-coated HNTs are revealed by red fluorescence derived from a PAA-Rhodamine 6G-conjugated polymer layer.
III. RESULTS AND DISCUSSION
A. LbL Assembly of Polyelectrolyte Multilayers Onto HNTs
By using ζ-potential measurements a typical alternate (positive\negative\positive and so on) signal is detected, demonstrating the successful coating process of PLL and PAA onto the surface of naked HNTs. Furthermore the ζ-potential value over 30 mV suggested a good colloidal stability during the formation of polymer coating layers onto HNTs (see Fig. 2) .
B. Curcumin Loading Efficiency and Release Kinetics
A typical EE of around 75-80 wt% and a LE of about 7-10 wt% were observed for curcumin in the optimised experimental condition (e.g., H total = 3000 μg and C total = 500 μg as shown in Table I ). The in vitro release profile (see Fig. 3 ) showed a constant and slow kinetics, which led to the release of around 40% of the drug in 24 h. When HNTs were coated by the LbL technique, a further slow-down of the release rate was observed, with less than 20% of drug in the external release medium in 24 h. This demonstrated the possibility to create an effective barrier to the drug diffusion, which can be controlled by choosing the number of layers on the tubes external surface. A similar report about LbL assembly of polyelectrolyte multilayers into HNTs demonstrated also a significant retarded drug (in this case dexamethasone) release caused by polymer coating [10] .
C. Curcumin Cytotoxicity and HNTs Biocompatibility
The MTT assay conducted for curcumin demonstrated a high cytotoxicity of the drug on MCF-7, with a IC 50 of 30 μM (corresponding to 10 μg/mL) in the first 24 h, and lower for further incubation times.
On the other hand, either naked or coated HNTs, showed a good biocompatibility on the tested cell line, until concentrations of 250 μg/mL (see Fig. 4 ).
The CV was well preserved until concentrations of 100 μg/mL, even after 72 h of incubation, when the CV appeared to be at around 70% after treatment with naked HNTs, and even higher with coated HNTs, near to 80%. The CV continued to maintain high values also for concentrations of 250 μg/mL until 48 h.
These results were comparable with others obtained in previous studies about the biocompatibility of HNTs, both naked and coated with different types of polymers [5] , [11] .
D. Effect of Loaded HNTs on CV
A progressive reduction in CV was observed after treatment with increasing concentrations of loaded HNTs. The effect was proportional to the concentration of loaded tubes and the incubation time (see Fig. 5 ). The CV continued to maintain high values in the first 24 h, probably due to the presence of just a small amount of drug in the medium. The effect was higher after 48 h, when the CV fell to 60% in the presence of 100 μg/mL of HNTs, and to around 40% for concentrations of 250 μg/mL. The cytotoxicity profile was similar after 72 h, compatibly with the slow release rate of the drug.
E. Uptake and Release of Curcumin-Loaded HNTs by MCF-7
HNTs are readily up-taken by MCF-7 cells as confirmed by CLSM images (see Fig. 6 ). In particular a characteristic 
IV. CONCLUSION
HNTs represent an innovative system for drug delivery and controlled release. Their abundance in nature, along with their simple loading procedure, make them good candidates as drug carriers. In this study, HNTs were characterized in terms of structure and biocompatibility, and they were used as carriers for curcumin, a natural polyphenol with good pharmaceutical properties. Previous studies had already shown the possibility to load these tubes with other types of drugs, and to cover them with different polymers, by a simply LbL technique. We demonstrated a high biocompatibility of HNTs, both naked and coated, until concentrations of 100 μg/mL, and even until 250 μg/mL for lower incubation times. A typical loading efficiency of around 7-10% (w/w) was observed for curcumin, followed by a constant and slow release. The release kinetics could be affected by adding a series of different polycations to the external surface of HNTs. The CV of the tested cell line showed a progressive reduction after treatment with loaded tubes, compatibly with the drug release kinetics. CLSM demonstrated the successful internalization and release of HNTs inside breast cancer cells. In particular curcumin is readily delivered inside MCF-7 cells after 24 h and is slowly released through polyelectrolyte multilayers coating. All together our results envisaged the use of HNTs as efficient nano-carriers for polyphenols delivery.
